Log In
Print
BCIQ
Print
Print this Print this
 

CB-5945 (formerly ADL5945, OpRA III)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionMu opioid receptor (OPRM1; MOR) antagonist
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor antagonist
Latest Stage of DevelopmentPhase III
IndicationConstipation
Partner

Cubist Pharmaceuticals Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today